Webbplatsen kommer inte fungerar helt korrekt om er webbläsares JavaScript funktion är inaktiverad.
}
Fighting antibiotic resistance

Amferia

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia's core focus is preventive healthcare and wound care where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria.

Amferia

CEO:

Anand Kumar Rajasekharan

First investment year:

2020

Business sector:

Life Science, Medtech

Investment manager: Louise Warme Visit website